In particular, MOF was identified to suppress epithelial-to-mesenchymal transition (EMT) via the acetylation of histone demethylase LSD1 in lung cancer and BC, and higher expression of MOF is correlated with favorable prognosis in these two cancers (19, 23, 24). Here, KAT8 is linked to breast cancer.